Table 2.

Clinical Data of Infants With Symptomatic GER

SexGA (Weeks)PCA (Weeks)PCA (Weeks)BW (g)Pre SPost SCCO2O2
 1M243536763YesYesNoNo
 2M273132900YesNo1916NoNo
 3* M2935361376YesNoYesYes
 4* M364748980NoYesYesYes
 5M273435957YesNo15YesYes
 6F2830311261YesNo1615YesNo
 7F3032331381YesNoNoNo
 8F263738891YesNoYesYes
 9M3135361259YesNo14NoNo
10M2839401253YesNoYesYes
11* F263738803YesNoYesYes
12F3436372263NoNo15NoNo
13F283031899YesNo1318NoNo
14* M3236371741NoNoNoNo
15M3236371600NoNoNoNo
16M2536371086YesYesYesYes
17M283334946YesYes2715YesYes
18M283132872YesYes1713YesYes
19* F3234351412YesYes920YesYes
20F3031321400YesNo2112NoNo
21* M254243631YesYesYesYes
22M3233341665YesNo1218NoNo
23M254748822YesYesNoNo
24* M283536884YesNo2223YesYes
  • Pre S indicates prenatal steroids; post S, postnatal steroids; —, no caffeine; C, caffeine level (μg/mL); O2, nasal oxygen; BW, birth weight; M, male; F, female.

  • * Infants who had no decrease in RI after cisapride (see also Tables 4 and 5).

  • Baseline study.

  • ≥48 hours after cisapride.